Percutaneous transluminal stenting for superior vena cava syndrome caused by malignant tumors: a single-center retrospective study.
Haitao LiuYahua LiYang WangLei YanPengli ZhouXin-Wei HanPublished in: Journal of cardiothoracic surgery (2021)
For superior vena cava syndrome caused by malignant tumors, percutaneous endoluminal stent therapy can quickly and effectively relieve the clinical symptoms of patients, and the incidence of complications is low.
Keyphrases
- vena cava
- inferior vena cava
- end stage renal disease
- risk factors
- ejection fraction
- minimally invasive
- chronic kidney disease
- newly diagnosed
- ultrasound guided
- peritoneal dialysis
- case report
- radiofrequency ablation
- pulmonary embolism
- mesenchymal stem cells
- coronary artery disease
- acute coronary syndrome
- physical activity
- sleep quality